Martin Teichmann

The "Targeting Transcription in Breast Cancer" team aims to elucidate molecular mechanisms underlying the development of breast cancer and hopes to use this knowledge to find new treatments. Our work focuses primarily on transcriptional activities in triple negative and molecular apocrine breast cancer. The team is composed of clinicians, bioinformaticians, pathologists and molecular biologists.